Valuation: Stratec SE

Market Cap 238M 272M 219M 202M 381M 26.17B 389M 2.62B 1.03B 12.82B 1.02B 998M 44.13B P/E 2026 *
19x
P/E 2027 * 13x
Enterprise Value 338M 387M 312M 288M 542M 37.26B 554M 3.73B 1.47B 18.25B 1.45B 1.42B 62.82B EV / Sales 2026 *
1.27x
EV / Sales 2027 * 1.18x
Free-Float
39.72%
Yield 2026 *
3.43%
Yield 2027 * 3.95%
1 week+2.80%
Current month+12.65%
1 month+5.54%
3 months-3.93%
6 months-18.89%
Current year-14.34%
1 week 18.44
Extreme 18.44
19.92
1 month 16.36
Extreme 16.36
19.92
3 years 16.3
Extreme 16.3
61
5 years 16.3
Extreme 16.3
147
10 years 16.3
Extreme 16.3
147
Manager TitleAgeSince
Chief Executive Officer 59 2011-03-31
Director of Finance/CFO 38 2025-10-31
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2019-05-28
Director/Board Member 73 2020-07-20
Chairman 68 2022-05-19
Change 5-day change 1-year change 3-year change Capi.($)
-2.56%+2.80%-32.65%-68.44% 272M
-1.97%+1.03%+28.39%-0.57% 198B
-0.58%+2.40%+7.25%-16.42% 144B
-14.15%-15.08%-33.40%-1.22% 122B
-1.32%-1.65%-57.52%-15.88% 65.44B
-2.40%-7.03%+12.08%-6.43% 49.36B
-0.11%+1.53%-23.83%-31.33% 44.74B
-3.41%-2.11%+15.33%+6.81% 37.13B
-2.44%-1.98%+28.33%+31.74% 36.23B
-1.86%-2.39%-22.85%-8.74% 28.7B
Average -3.14%-2.32%-7.89%-11.05% 80.68B
Weighted average by Cap. -3.69%-1.84%-1.00%-5.86%

Financials

2026 *2027 *
Net sales 267M 306M 246M 227M 428M 29.44B 438M 2.95B 1.16B 14.42B 1.15B 1.12B 49.63B 284M 325M 262M 241M 455M 31.28B 465M 3.13B 1.23B 15.32B 1.22B 1.19B 52.74B
Net income 14.02M 16.05M 12.94M 11.93M 22.48M 1.55B 22.98M 155M 60.83M 757M 60.26M 58.94M 2.61B 18.29M 20.92M 16.87M 15.55M 29.31M 2.02B 29.97M 202M 79.33M 987M 78.58M 76.86M 3.4B
Net Debt 101M 115M 92.83M 85.56M 161M 11.09B 165M 1.11B 436M 5.43B 432M 423M 18.69B 97.7M 112M 90.15M 83.1M 157M 10.77B 160M 1.08B 424M 5.27B 420M 411M 18.15B
Logo Stratec SE
Stratec SE is a Germany-based company. The Company is engaged in development and manufacture of analyzer systems, and it is also performing and managing administrative and organizational tasks for laboratory markets. Stratec is providing automation solutions and instrumentation of biochemical processes using hardware and software for in-vitro diagnostics and life science companies. It also developing and integrating instrumentation, complex consumables and software by covering virtually the entire value chain for specification, design, manufacture and approval of complex analyzer system solutions.
Employees
-
Date Price Change
26-07-17 €19.06 -2.56%
26-07-16 €19.56 +2.41%
26-07-15 €19.10 +2.03%
26-07-14 €18.72 +0.21%
26-07-13 €18.68 +0.76%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
19.54EUR
Average target price
25.40EUR
Spread / Average Target
+29.99%

Annual profits - Rate of surprise